Mark N. Diker, Director at CANTEL MEDICAL CORP (CMN), bought 5,000 shares at $9.85 ($49K) on 2008-03-07, disclosed to the SEC on 2008-03-07.
Open-market purchase of $49k CMN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CMD | SELL | 2017-10-05 | $692K | — | Filing → |
| CMN | SELL | 2016-06-14 | $513K | — | Filing → |
| CMN | SELL | 2015-10-02 | $566K | — | Filing → |